Bone Biologics Corp (BBLG)
NASDAQ · Manufacturing · Orthopedic, prosthetic & surgical appliances & supplies
$0.4960+$0.0048 (+0.98%) on the dayAs of the close; data may be delayed.
BBLG price, last 12 months
Key stats
- Previous close
- $0.4912
- Open
- $0.4879
- Day range
- $0.4700 – $0.4963
- 52-week range
- $0.4280 – $2.89
- Volume
- 59.8K
- Avg volume (20 days)
- 309.3K
- Market cap
- $1.4M
Performance
1W−4.4%
1M−19.5%
3M−64.6%
6M−55.5%
YTD−65.8%
1Y−76.9%
vs S&P 500, 1Y−93.7 pts
Technicals and fundamentals
About Bone Biologics Corp
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
- Sector
- Manufacturing
- Industry
- Orthopedic, prosthetic & surgical appliances & supplies
- Listed on
- NASDAQ
- Market cap
- $1.4M